BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1679639)

  • 1. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
    Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
    Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene amplification in squamous cell carcinoma of the oral cavity.
    Saranath D; Panchal RG; Nair R; Mehta AR; Sanghavi V; Sumegi J; Klein G; Deo MG
    Jpn J Cancer Res; 1989 May; 80(5):430-7. PubMed ID: 2502519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Harvey ras heterozygosity in oral squamous carcinoma.
    Howell RE; Wong FS; Fenwick RG
    J Oral Pathol Med; 1989 Feb; 18(2):79-83. PubMed ID: 2568483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene amplifications, rearrangements, and restriction fragment length polymorphisms in human leukaemia.
    Boehm TL; Hirth HP; Kornhuber B; Drahovsky D
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):623-9. PubMed ID: 2888656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple genetic lesions in laryngeal squamous cell carcinomas.
    Fracchiolla NS; Pignataro L; Capaccio P; Trecca D; Boletini A; Ottaviani A; Polli E; Maiolo AT; Neri A
    Cancer; 1995 Mar; 75(6):1292-301. PubMed ID: 7882279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of gene amplification in head-and-neck squamous-cell carcinoma.
    Leonard JH; Kearsley JH; Chenevix-Trench G; Hayward NK
    Int J Cancer; 1991 Jun; 48(4):511-5. PubMed ID: 2045198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions.
    Pelisson I; Soler C; Pechoux C; Chignol MC; Viac J; Euvrard S; Chardonnet Y
    J Dermatol Sci; 1992 Jan; 3(1):56-67. PubMed ID: 1317208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of restriction fragment length polymorphisms of proto-oncogenes in native Hawaiians and other ethnic groups in Hawaii.
    Riley HD; Lau AF; Humphreys T
    Hum Hered; 1992; 42(4):209-15. PubMed ID: 1355072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
    Ishiguro N; Matsui T; Shinagawa M
    Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
    Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
    J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of oncogenes in lung carcinoma grafted in nude mice.
    Chauvin C; Jacrot M; Riondel J; Brambilla E; Foote AM; Brambilla C; Benabid AL
    Anticancer Res; 1989; 9(2):449-52. PubMed ID: 2568771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies.
    Miyazaki S; Sasno H; Shiga K; Sawai T; Nishihira T; Okamoto H; Mori S
    Anticancer Res; 1992; 12(5):1747-55. PubMed ID: 1444241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
    Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
    Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
    Somers KD; Cartwright SL; Schechter GL
    Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oncogene expression in malignant head and neck neoplasia].
    Sartoris A; Aluffi P; Montemagno A; Gerbaudo EV; Gariglio M; Cavallo GP
    G Batteriol Virol Immunol; 1991; 84(1-12):25-30. PubMed ID: 1844916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man].
    Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF
    Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic typing of non-Hodgkin's lymphomas by in situ hybridization with DNA probes of oncogenes.
    Hamatani K; Yoshida K; Kondo H; Toki H; Okabe K; Motoi M; Ikeda S; Mori S; Shimaoka K; Akiyama M
    Blood; 1989 Jul; 74(1):423-9. PubMed ID: 2526666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variability of proto-oncogenes for breast cancer risk and prognosis.
    Lidereau R; Mathieu-Mahul D; Escot C; Theillet C; Champeme MH; Cole S; Mauchauffe M; Ali I; Amione J; Callahan R
    Biochimie; 1988 Jul; 70(7):951-9. PubMed ID: 2905174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance.
    Nagai MA; Habr-Gama A; Oshima CT; Brentani MM
    Dis Colon Rectum; 1992 May; 35(5):444-51. PubMed ID: 1373678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.